Teleflex Inc
NYSE:TFX

Watchlist Manager
Teleflex Inc Logo
Teleflex Inc
NYSE:TFX
Watchlist
Price: 191.01 USD -1.86% Market Closed
Market Cap: 8.9B USD
Have any thoughts about
Teleflex Inc?
Write Note

Teleflex Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Teleflex Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Teleflex Inc
NYSE:TFX
Revenue
$3B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
5%
Becton Dickinson and Co
NYSE:BDX
Revenue
$20.2B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$22B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$41.2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%
No Stocks Found

Teleflex Inc
Revenue Breakdown

Breakdown by Geography
Teleflex Inc

Total Revenue: 3B USD
100%
United States: 1.9B USD
63.2%
Europe: 665.2m USD
22.4%
Asia Pacific: 307.5m USD
10.3%
All Other: 121.9m USD
4.1%
Show More
Show Less

Breakdown by Segments
Teleflex Inc

Total Revenue: 3B USD
100%
Vascular Access: 708m USD
23.8%
Interventional: 511.4m USD
17.2%
Surgical: 427.4m USD
14.4%
Anesthesia: 390m USD
13.1%
Oem: 326m USD
11%
Interventional Urology: 319.8m USD
10.8%
Other: 291.9m USD
9.8%
Show More
Show Less

Teleflex Inc
Glance View

Market Cap
8.9B USD
Industry
Health Care

Teleflex Inc. is a global provider of medical technologies designed to enhance patient outcomes and improve efficiency in healthcare systems. Founded in 1943, the company has established itself as a leader in the medical device industry, focusing primarily on areas such as vascular access, anesthesia, urology, and surgical interventions. Teleflex's innovative products, ranging from catheters to advanced surgical tools, are essential in diverse medical settings, including hospitals and outpatient facilities. With a commitment to research and development, Teleflex invests heavily in new technologies, positioning itself to address the evolving needs of healthcare professionals and patients worldwide. For investors, Teleflex represents a compelling opportunity in the fast-growing healthcare sector, bolstered by its robust portfolio of patented offerings and strong market presence. The company has demonstrated resilience and adaptability, maintaining steady revenue growth and profitability even amidst shifting market dynamics. With an expanding global footprint and strategic acquisitions aimed at enhancing its product line, Teleflex not only aims to capture emerging trends in healthcare but also to deliver consistent value to its shareholders. As the demand for innovative medical solutions continues to rise, Teleflex is well-poised to play a pivotal role in shaping the future of patient care while presenting a potentially lucrative investment opportunity.

TFX Intrinsic Value
275.23 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Teleflex Inc's Revenue?
Revenue
3B USD

Based on the financial report for Sep 29, 2024, Teleflex Inc's Revenue amounts to 3B USD.

What is Teleflex Inc's Revenue growth rate?
Revenue CAGR 10Y
5%

Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Teleflex Inc have been 3% over the past three years , 3% over the past five years , and 5% over the past ten years .

Back to Top